These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 39336561)

  • 21. Over-the-counter nonsteroidal anti-inflammatory drugs and risk of gastrointestinal symptoms.
    Thomas J; Straus WL; Bloom BS
    Am J Gastroenterol; 2002 Sep; 97(9):2215-9. PubMed ID: 12358235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Epidemiology of gastroduodenal complications associated with nonsteroidal anti-inflammatory drug use].
    Merle V; Thiéfin G; Czernichow P
    Gastroenterol Clin Biol; 2004 Apr; 28 Spec No 3():C27-36. PubMed ID: 15366672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case-control study of the risk of upper gastrointestinal mucosal injuries in patients prescribed concurrent NSAIDs and antithrombotic drugs based on data from the Japanese national claims database of 13 million accumulated patients.
    Sugisaki N; Iwakiri R; Tsuruoka N; Sakata Y; Shimoda R; Fujimoto S; Eguchi Y; Fujimoto K
    J Gastroenterol; 2018 Dec; 53(12):1253-1260. PubMed ID: 29948304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of hospitalization with peptic ulcer disease or gastrointestinal hemorrhage associated with nabumetone, Arthrotec, diclofenac, and naproxen in a population based cohort study.
    Ashworth NL; Peloso PM; Muhajarine N; Stang M
    J Rheumatol; 2005 Nov; 32(11):2212-7. PubMed ID: 16265705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications.
    Lewis JD; Bilker WB; Brensinger C; Farrar JT; Strom BL
    Am J Gastroenterol; 2002 Oct; 97(10):2540-9. PubMed ID: 12385436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastrointestinal events in at-risk patients starting non-steroidal anti-inflammatory drugs (NSAIDs) for rheumatic diseases: the EVIDENCE study of European routine practice.
    Lanas A; Boers M; Nuevo J
    Ann Rheum Dis; 2015 Apr; 74(4):675-81. PubMed ID: 24351518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of gastrointestinal and cardiovascular risk in patients with osteoarthritis who require NSAIDs: the LOGICA study.
    Lanas A; Tornero J; Zamorano JL
    Ann Rheum Dis; 2010 Aug; 69(8):1453-8. PubMed ID: 20498210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
    Turajane T; Wongbunnak R; Patcharatrakul T; Ratansumawong K; Poigampetch Y; Songpatanasilp T
    J Med Assoc Thai; 2009 Dec; 92 Suppl 6():S19-26. PubMed ID: 20128070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential Risk of Peptic Ulcer Among Users of Antidepressants Combined With Nonsteroidal Anti-inflammatory Drugs.
    Shin JY; Song I; Lee JH; Yoon JL; Kwon JS; Park BJ
    J Clin Psychopharmacol; 2017 Apr; 37(2):239-245. PubMed ID: 28166082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An epidemiological approach to assess the economic burden of NSAID-induced gastrointestinal events in The Netherlands.
    Herings RM; Klungel OH
    Pharmacoeconomics; 2001; 19(6):655-65. PubMed ID: 11456213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of gastrointestinal complications associated to NSAIDs, low-dose aspirin and their combinations: Results of a pharmacovigilance reporting system.
    Rafaniello C; Ferrajolo C; Sullo MG; Sessa M; Sportiello L; Balzano A; Manguso F; Aiezza ML; Rossi F; Scarpignato C; Capuano A
    Pharmacol Res; 2016 Feb; 104():108-14. PubMed ID: 26739516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of uncomplicated peptic ulcer disease in a cohort of new users of low-dose acetylsalicylic acid for secondary prevention of cardiovascular events.
    Ruigómez A; Johansson S; Nagy P; Martín-Pérez M; Rodríguez LA
    BMC Gastroenterol; 2014 Dec; 14():205. PubMed ID: 25492031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prescription pattern of NSAIDs and the prevalence of NSAID-induced gastrointestinal risk factors of orthopaedic patients in clinical practice in Korea.
    Lee SH; Han CD; Yang IH; Ha CW
    J Korean Med Sci; 2011 Apr; 26(4):561-7. PubMed ID: 21468265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cross-sectional study of factors related to gastrointestinal drug use in Korean adolescents.
    Lee KE; Hwang SJ; Gwak HS; Lee BK; Bae SJ; Rhie S
    Arch Pharm Res; 2013 Oct; 36(10):1238-43. PubMed ID: 23918647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An endoscopic study of gastroduodenal lesions induced by nonsteroidal anti-inflammatory drugs.
    Cheatum DE; Arvanitakis C; Gumpel M; Stead H; Geis GS
    Clin Ther; 1999 Jun; 21(6):992-1003. PubMed ID: 10440623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review of the gastrointestinal safety data--a gastroenterologist's perspective.
    Lanas A
    Rheumatology (Oxford); 2010 May; 49 Suppl 2(Suppl 2):ii3-10. PubMed ID: 20407138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events.
    Hunt RH; Harper S; Watson DJ; Yu C; Quan H; Lee M; Evans JK; Oxenius B
    Am J Gastroenterol; 2003 Aug; 98(8):1725-33. PubMed ID: 12907325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inappropriate prevention of NSAID-induced gastrointestinal events among long-term users in the elderly.
    Lanas A; Ferrandez A
    Drugs Aging; 2007; 24(2):121-31. PubMed ID: 17313200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment.
    Hawkey C; Kahan A; Steinbrück K; Alegre C; Baumelou E; Bégaud B; Dequeker J; Isomäki H; Littlejohn G; Mau J; Papazoglou S
    Br J Rheumatol; 1998 Sep; 37(9):937-45. PubMed ID: 9783757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptic ulcer disease risk in chronic kidney disease: ten-year incidence, ulcer location, and ulcerogenic effect of medications.
    Liang CC; Muo CH; Wang IK; Chang CT; Chou CY; Liu JH; Yen TH; Huang CC; Chung CJ
    PLoS One; 2014; 9(2):e87952. PubMed ID: 24498412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.